VRTX

Vertex Pharmaceuticals Incorporated

Halal Rating :
Comfortable
Last Price $397.20 Last updated:
Market Cap $127.99b
7D Change -14.35%
1 Year Change -0.86%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NASDAQ
Next Earnings Date Nov. 4, 2024

Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis and other serious diseases. Vertex's business model centers on discovering, developing, manufacturing and commercializing innovative medicines.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $2.77b $1.66b - $7.5m 0.00% 0.45%
June 30, 2024 $2.65b $6.17b - $9.9m 0.00% 0.16%
March 31, 2024 $2.69b $1.56b - $10.4m 0.00% 0.67%

Company Impact

Help us evaluate Vertex Pharmaceuticals Incorporated's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates